Literature DB >> 1422098

Elevation of plasma atrial natriuretic peptide occurs during adrenaline infusion in hypertensive but not normotensive subjects.

T J Tunny1, R D Gordon, A W Bachmann, S A Klemm.   

Abstract

The levels of plasma atrial natriuretic peptide in response to graded adrenaline infusion were determined in six patients with essential hypertension and six healthy normotensive subjects (controls). Basal plasma adrenaline concentration was similar in both groups and rose progressively and to a similar level during adrenaline infusion. Plasma noradrenaline rose in both groups and to the same extent during the 26 and 39 ng/kg/min adrenaline infusion rates. Basal plasma atrial natriuretic peptide levels were higher in the hypertensives than in the controls. Graded adrenaline infusion had no effect on atrial natriuretic peptide levels in the controls but significantly raised atrial natriuretic peptide levels in the hypertensives. Systolic blood pressure rose progressively during adrenaline infusion at a lower infusion rate in the hypertensives than in the controls. Similarly, while heart rate rose during adrenaline infusion in both groups, there was a greater rise in the hypertensives. The increased cardiovascular responsiveness to adrenaline infusion in patients with essential hypertension may explain why plasma atrial natriuretic peptide levels rose only in this group and not the normotensive subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422098     DOI: 10.1007/bf01824300

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  32 in total

Review 1.  Stress and hypertension--a critical review.

Authors:  Z S Freeman
Journal:  Med J Aust       Date:  1990-11-19       Impact factor: 7.738

2.  Support for adrenaline-hypertension hypothesis: 18 hour pressor effect after 6 hours adrenaline infusion.

Authors:  P J Blankestijn; A J Man in't Veld; J Tulen; A H van den Meiracker; F Boomsma; P Moleman; H J Ritsema van Eck; F H Derkx; P Mulder; S J Lamberts
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

3.  Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.

Authors:  S A Klemm; T J Tunny; R D Gordon
Journal:  J Hypertens Suppl       Date:  1987-12

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  Evidence for alpha-1 adrenergic receptor regulation of atriopeptin release from the isolated rat heart.

Authors:  M G Currie; W H Newman
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

6.  Epinephrine increases plasma immunoreactive atrial natriuretic hormone levels in humans.

Authors:  J A Sanfield; Y Shenker; R J Grekin; S G Rosen
Journal:  Am J Physiol       Date:  1987-06

7.  Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptide.

Authors:  D G Gardner; H D Schultz
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

8.  Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

Authors:  I Tikkanen; F Fyhrquist; K Metsärinne; R Leidenius
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

9.  Increased plasma levels of atrial natriuretic peptide (ANP) in patients with paroxysmal supraventricular tachyarrhythmias.

Authors:  G Nilsson; A Pettersson; J Hedner; T Hedner
Journal:  Acta Med Scand       Date:  1987

10.  Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations.

Authors:  A M Richards; D McDonald; M A Fitzpatrick; M G Nicholls; E A Espiner; H Ikram; S Jans; S Grant; T Yandle
Journal:  J Clin Endocrinol Metab       Date:  1988-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.